Bermele Share Price (BERM)

Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Bermele Plc LSE:BERM London Ordinary Share GB00BJ1F3295 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 0.75 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -0.51 -0.24 2
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 0.75 GBX
Related Shares
Astrazeneca (AZN), Gsk (GSK), N4 Pharma (N4P), Motif Bio (MTFB)

Bermele (BERM) Latest News

Bermele News

Date Time Source Headline
16/7/202110:23UKREGBermele PLC Result of GM
More Bermele News
Bermele Investors    Bermele Takeover Rumours

Bermele (BERM) Discussions and Chat

Bermele Forums and Chat

Date Time Title Posts
19/7/202116:16Regan's new shell42
24/3/202113:35Bermele with Charts & News1
30/4/202011:34COVID 19 Shell19

Add a New Thread

Bermele (BERM) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Bermele trades in real-time

Bermele (BERM) Top Chat Posts

DateSubject
06/7/2022
09:20		Bermele Daily Update: Bermele Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker BERM. The last closing price for Bermele was 0.75p.
Bermele Plc has a 4 week average price of 0p and a 12 week average price of 0p.
The 1 year high share price is 0p while the 1 year low share price is currently 0p.
There are currently 222,000,000 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Bermele Plc is £1,665,000.
Read Full Thread
Reply
06/7/2021
02:26		garreyd: Dunno about you but im getting a real stuff on thinking about this deal. Could be a masterstroke. Only taken half a decade to put together lol. Just hope we dont see the usual pump n dump yknow. Between me n the lads reckon we got bout 200k in BERM. Hold on open n see where it takes us. As ye were
Read Full Thread
Follow
Reply
21/6/2021
15:31		thirdmanharry: Article in THe Times 2 June 2021 reported: "A New Zealand-based supplier of upmarket mixers that is aiming to establish itself as a global No 2 to Fever-Tree Drinks is set to list on Aim with a market value of £30 million. East Imperial, co-founded in 2012 by Tony Burt, a former chief executive of M&C Saatchi New Zealand, is listing by means of a reverse takeover of Bermele, a cash shell, in which Burt, 50, will emerge with a 21.4 per cent stake. Alongside the listing, East Imperial, which is being advised by Optiva Securities, a boutique broker, will raise £3 million of new funds through a placing of 30 million shares at 10p a share to finance its growth ambitions. Like Fever-Tree, East Imperial prides itself on the quality of its ingredients, with its tonic water containing quinine from the bark of cinchona trees hand- picked in Java. Its other mixers include yuzu and grapefruit tonics, Mombasa Ginger Beer and Kima Kola, which has allowed it to target the dark spirits market. The company also has a collaboration with the Royal Botanic Gardens in London called Royal Botanic Tonic. Other strands to its business include an organic tonic and low-calorie flavoured soda waters, including pineapple and kombu and blueberry and white tea ranges. It is also poised to launch a coffee and tonic drink after completing trials. Although it does not sell its drinks in Britain, where Fever-Tree has a dominant position, it is taking on its bigger rival in much of Asia-Pacific, including China, and in the United States. It has a modest presence in Europe. Whereas Fever-Tree sells to both “on-trade̶1; buyers — bars, pubs and restaurants — and supermarkets, East Imperial’s main customers are five-star hotels and premium bars and restaurants. The lockdowns have driven a surge in sales through its website. Its most prestigious customers include the Mondrian South Beach, in Miami, the Peninsula in Chicago and the Ritz-Carlton, Shanghai, as well as the Atlas Bar in Singapore. According to its presentation, in 2019 it was rated the No 3 top trending tonic brand as well as the No 3 top selling tonic brand by Drinks International, the industry magazine, based on votes from the world’s top 50 bars. The company reported revenue of £2.68 million in 2019, which fell to £1.75 million last year because of the pandemic. Its operating losses narrowed from £853,000 to £813,000, while pre-tax losses fell from £888,000 to £850,000. Bermele, which will change its name to East Imperial, was floated on Aim in May 2019 to acquire businesses in the pharmaceutical and biotechnology sector and last year it widened the search for targets to other sectors. Last July it entered exclusive talks over a reverse takeover by East Imperial."
Read Full Thread
Follow
Reply
24/3/2021
13:35		geoff80: For Immediate Release 8 March 2021 Bermele Plc ("Bermele" or "the Company") Convertible Loan Agreement Bermele has entered into a Convertible Loan Agreement for GBP100,000 ("Loan") with a private investor. The Loan, which is for a fixed term of 12 months and carries no interest, is repayable or convertible at the Lender's discretion into new Ordinary Shares in the Company at 0.6 pence per share. The proceeds from the Loan are to be used for working capital pending completion of the potential acquisition of East Imperial Pte. Ltd as announced by the Company on 20 July 2020. Preparations for the publication of a prospectus and admission of the enlarged group to trading on the London Stock Exchange are well advanced. The transaction remains conditional, inter alia, on consent from the Financial Conduct Authority for the re-admission of the enlarged share capital to the Official List (by way of Standard Listing under Chapter 14 of the Listing Rules).
Read Full Thread
Follow
Reply
28/4/2020
21:27		milliecusto: Dog of a share, by the time they find a company covid will be cured, much better shares to buy than a tax break
Read Full Thread
Follow
Reply
28/4/2020
18:33		imjustdandy: The Company has been formed for the purpose of acquiring a business or businesses operating in the pharmaceutical and and biotechnology sectors. The acquisition of either the assets or the share capital of a target company, will be treated as a reverse Takeover and in order to maintain it's listing the enlarged group, would be required to apply to have its shares readmitted to the Official List and trading on the Main Market of the London Stock Exchange.
Read Full Thread
Follow
Reply
28/4/2020
18:29		imjustdandy: BERM have been on the look out for a Pharma / Bio Co to reverse into their shell. If ever there was a time its now.
Read Full Thread
Follow
Reply
17/10/2019
06:28		newtothisgame3: #HNG why its a penalty kick v #BERM significance Dwight Mighty coming back on board with regard to the RTO I've had a look at his involvements he has a company called Modwena Sports Advisors Ltd It's a fit for the RTO tax losses scenario,possibly https://twitter.com/smallcappick/status/1184686457723727872
Read Full Thread
Follow
Reply
16/10/2019
21:01		newtothisgame3: #HNG why its a penalty kick v #BERM significance Dwight Mighty coming back on board with regard to the RTO I've had a look at his involvements on Companies House and note that he has a company called Modwena Sports Advisors Ltd It's a fit for the RTO tax losses scenario,possibly https://twitter.com/smallcappick/status/1184559479339343872
Read Full Thread
Follow
Reply
15/10/2019
14:38		newtothisgame3: #HNG look at the premium req for not a large amount come on #BERM guys wakey wakey #HNG is a better option https://twitter.com/smallcappick/status/1184099726368612352
Read Full Thread
Follow
Reply
11/10/2019
17:40		dave4545: Not your style to post the truth and say the 2 x 1 mil were a rollover cudmore. Is 69 going to make a appearance ? clanger @clancy3105 · 12m #BERM you have to feel for those idiots who sold before the 1m buys popped up 😆😆😆
Read Full Thread
Follow
Reply
Bermele share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
BERM
Bermele
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220706 12:15:45